Lauren E Thompson1,2, Frederick A Masoudi1,2, Kensey L Gosch3, Pamela N Peterson1,2,4, Philip G Jones3, Adam C Salisbury3,5, Mikhail Kosiborod3,5, Stacie L Daugherty1,2. 1. Division of Cardiology, Aurora, Colorado. 2. Colorado Cardiovascular Outcomes Research Consortium, University of Colorado at School of Medicine, Aurora, Colorado. 3. Saint Luke's Mid America Heart Institute, Kansas City, Missouri. 4. Division of Cardiology, Denver Health Medical Center, Denver, Colorado. 5. Division of Cardiology, University of Missouri-Kansas City in Kansas, Kansas City, Missouri.
Abstract
BACKGROUND: Anemia at discharge in patients with acute myocardial infarction is associated with poor prognosis; whether this differs in women and men or if there is a threshold value at which these relationships change is unknown. HYPOTHESIS: Women have a lower discharge hemoglobin (Hb) at which outcomes worsen. METHODS: We identified patients with acute myocardial infarction in the TRIUMPH registry between 2005 and 2008. In multivariable models, we evaluated the relationship between discharge Hb and 12-month mortality and tested whether this relationship varied by gender. We assessed whether the relationship with discharge Hb values was nonlinear using a restricted cubic spline term. RESULTS: Of 4243 patients with AMI, 32.9% were female. Mean admission Hb was 12.9 ± 1.9 g/dL in women and 14.5 ± 2.0 g/dL in men, with mean discharge Hb 11.4 ± 1.8 g/dL and 12.9 ± 1.9 g/dL, respectively. Lower discharge Hb was independently associated with increased mortality (P < 0.05). In multivariable models, discharge Hb decline was similarly associated with increased 12-month mortality in women and men (per 1-g/dL decrease Hb; women HR: 1.24, 95% CI: 1.09-1.42, P < 0.01; and men HR: 1.25, 95% CI: 1.13-1.37, P < 0.01; P for gender interaction = 0.99). The relationship between discharge Hb and 12-month mortality was linear (P for nonlinear spline term = 0.12). CONCLUSIONS: Lower discharge Hb levels were similarly associated with increased 12-month mortality in women and men. These relationships are linear without a clear threshold, suggesting any decline in discharge Hb is associated with poor outcomes.
BACKGROUND:Anemia at discharge in patients with acute myocardial infarction is associated with poor prognosis; whether this differs in women and men or if there is a threshold value at which these relationships change is unknown. HYPOTHESIS: Women have a lower discharge hemoglobin (Hb) at which outcomes worsen. METHODS: We identified patients with acute myocardial infarction in the TRIUMPH registry between 2005 and 2008. In multivariable models, we evaluated the relationship between discharge Hb and 12-month mortality and tested whether this relationship varied by gender. We assessed whether the relationship with discharge Hb values was nonlinear using a restricted cubic spline term. RESULTS: Of 4243 patients with AMI, 32.9% were female. Mean admission Hb was 12.9 ± 1.9 g/dL in women and 14.5 ± 2.0 g/dL in men, with mean discharge Hb 11.4 ± 1.8 g/dL and 12.9 ± 1.9 g/dL, respectively. Lower discharge Hb was independently associated with increased mortality (P < 0.05). In multivariable models, discharge Hb decline was similarly associated with increased 12-month mortality in women and men (per 1-g/dL decrease Hb; women HR: 1.24, 95% CI: 1.09-1.42, P < 0.01; and men HR: 1.25, 95% CI: 1.13-1.37, P < 0.01; P for gender interaction = 0.99). The relationship between discharge Hb and 12-month mortality was linear (P for nonlinear spline term = 0.12). CONCLUSIONS: Lower discharge Hb levels were similarly associated with increased 12-month mortality in women and men. These relationships are linear without a clear threshold, suggesting any decline in discharge Hb is associated with poor outcomes.
Authors: Adam C Salisbury; Karen P Alexander; Kimberly J Reid; Frederick A Masoudi; Saif S Rathore; Tracy Y Wang; Richard G Bach; Steven P Marso; John A Spertus; Mikhail Kosiborod Journal: Circ Cardiovasc Qual Outcomes Date: 2010-05-20
Authors: Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2011-07
Authors: Harmony R Reynolds; Michael E Farkouh; A Michael Lincoff; Amy Hsu; Eva Swahn; Zygmunt P Sadowski; Jennifer A White; Eric J Topol; Judith S Hochman Journal: Arch Intern Med Date: 2007-10-22
Authors: M Moscucci; K A A Fox; Christopher P Cannon; W Klein; José López-Sendón; G Montalescot; K White; R J Goldberg Journal: Eur Heart J Date: 2003-10 Impact factor: 29.983
Authors: Ronald S McKechnie; Dean Smith; Cecelia Montoye; Eva Kline-Rogers; Michael J O'Donnell; Anthony C DeFranco; William L Meengs; Richard McNamara; John G McGinnity; Kirit Patel; David Share; Arthur Riba; Sanjaya Khanal; Mauro Moscucci Journal: Circulation Date: 2004-06-28 Impact factor: 29.690
Authors: Jean-Pierre Bassand; Rizwan Afzal; John Eikelboom; Lars Wallentin; Ron Peters; Andrzej Budaj; Keith A A Fox; Campbell D Joyner; Susan Chrolavicius; Christopher B Granger; Shamir Mehta; Salim Yusuf Journal: Eur Heart J Date: 2009-10-12 Impact factor: 29.983
Authors: Lauren E Thompson; Frederick A Masoudi; Kensey L Gosch; Pamela N Peterson; Philip G Jones; Adam C Salisbury; Mikhail Kosiborod; Stacie L Daugherty Journal: Clin Cardiol Date: 2017-12-16 Impact factor: 2.882
Authors: Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus Journal: Cardiovasc Res Date: 2021-01-21 Impact factor: 10.787